Herold KC, Bundy BN, Long SA, Bluestone JA, et al. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
PMID: 31180194